Farther Finance Advisors’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding GYRE
Farther Finance Advisors's GYRE Position: Q2 2026 in Review
Farther Finance Advisors opened a new position in Gyre Therapeutics (GYRE) in Q2 2026: 8 shares worth $53. The stake represents ﹤0.01% of the portfolio and ranks #5850 among its holdings.
4 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.
- Farther Finance Advisors held 8 shares of Gyre Therapeutics worth $53 as of Q2 2026.
- Gyre Therapeutics was a new Farther Finance Advisors position in Q2 2026.
- Gyre Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5850 holding.
- 4 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.
Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.